You are currently viewing a new version of our website. To view the old version click .

Non-invasive Delivery of Biologics: Formulation Strategies and Regulatory Aspects

Special Issue Information

Daer colleague,

Over the past two decades, biologics, ranging from small peptides to monoclonal antibodies, have revolutionized the treatment of difficult-to-treat diseases, notably cancer, metabolic disorders and systemic autoimmune diseases. Aiming to enhance patients’ adherence to the treatment and minimize the complications of the parenteral route, the non-invasive delivery of biologics is highly desired. This issue focuses on recently developed formulation strategies and novel delivery systems to advance the non-invasive administration of biological drugs, in addition to discussing regulatory aspects and future perspectives of biologics development.

Prof. Dr. Ildikó Csóka
Guest Editor
Dr. Ruba Ismail
Co-Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biologics
  • peptides
  • proteins
  • monoclonal antibodies
  • vaccines
  • biologics formulation
  • non-invasive delivery
  • nanomedicine
  • novel drug delivery systems
  • regulatory affairs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers